Electroencephalogram versus Magnetic Resonance Imaging Brain as the Initial Investigation of Choice in Neurologically Normal Children with First Afebrile Seizure in India
Abstract
Background and Purpose
To compare the rates of clinically relevant information provided by electroencephalogram (EEG) and magnetic resonance imaging (MRI) brain in first afebrile seizure (FAS) in children.
Methods
In this prospective randomized controlled trial, neurologically normal children between the age of 2 and 14 years, presenting with first episode of unprovoked, afebrile generalized or partial seizures, were included. Enrolled patients were randomized into two groups. After stabilization, initial workup and management, group I-patients underwent an EEG followed by MRI, whereas group II-patients underwent an initial MRI brain followed by an EEG. The patients were followed up after results of both the investigations and then every 3 months for seizure recurrence. The primary outcome was the proportion of investigations, providing clinically relevant information. The secondary outcomes were to determine the etiological diagnosis of FAS and record adverse events associated with EEG and MRI.
Results
Out of 170 enrolled patients, 52 patients (61.2%) in initial EEG group and 53 patients (70.6%) in initial MRI group had abnormal results on first investigation. An etiological diagnosis could not be made in any patient in initial EEG group. Neuroimaging revealed an etiological diagnosis in 53 patients (70.6%) in initial MRI group. Inflammatory granuloma was found to be the most common cause of FAS, followed by idiopathic epilepsy.
Introduction
Methods
This was a prospective randomized controlled trial conducted at the department of pediatrics in a tertiary care referral hospital catering to insured population in India. The study was approved by the Institutional Ethics Committee and registered at Clinical Trials Registry – India with registration number REF/2012/12/004374. Neurologically normal children between the age of 2 and 14 years, presenting with first episode of unprovoked, afebrile generalized or partial seizures (or suspected seizures), were included. Exclusion criteria were children with a history of developmental delay, abnormal head circumference, abnormal neurological examination and those with status epilepticus, seizures associated with an acute central nervous system infection (e.g., meningitis, encephalitis), head injury, systemic illness known to be associated with seizures (e.g., Shigella encephalopathy, subacute sclerosing panencephalitis), or recognizable dysmorphism or neurocutaneous syndrome. Patients admitted for suspicion of seizure but discharged with an alternative diagnosis (e.g., breath-holding spell). Pseudoseizure was also excluded from the study.
The following definitions were used for diagnosis and etiologic evaluations of the seizures: 1) first unprovoked afebrile seizure (FUS): one or multiple seizures within a 24-hour period with recovery of consciousness between episodes; 2) acute symptomatic: seizure in a previously neurologically normal child, within a week of an underlying etiology including central nervous system infection, encephalopathy, head trauma, cerebrovascular disease, and metabolic or toxic derangements; 3) remote symptomatic: seizure in the absence of an identified acute insult but with a history of a pre-existing neurological abnormality more than 1 week before; and 4) idiopathic epilepsy: seizure that is not symptomatic and occurred in a child with no prior neurological disorder or in a child in whom no neurological findings detected via physical examination. Idiopathic generalized epilepsy specifically refers to the epilepsy syndromes: juvenile myoclonic epilepsy, juvenile absence epilepsy, childhood absence epilepsy, and generalized tonic-clonic seizures alone.
Enrolled patients were randomized using computer-generated random numbers into two groups by a person, not directly involved in the conduct of the study. The random sequence was concealed using opaque labeled envelopes and opened at the time of allocation. After stabilization, initial workup and management, all the patients were subjected to both EEG and MRI in a sequential manner as per their group. Group I-patients first underwent an EEG followed by an MRI, whereas group II-patients underwent an initial MRI brain followed by an EEG. The initial workup also included hematological tests (complete blood count), biochemical tests (blood glucose, serum calcium, serum electrolytes (Na, K), blood urea and serum creatinine. Lumbar puncture and tuberculin skin test were done depending on the clinical status.
EEG protocol
The EEGs were performed using the standard 10–20 international system. All EEG recordings were done for 30 minutes duration with hyperventilation and intermittent photic stimulation at 1–30 Hz. Sleep deprived EEG with sleep deprivation of at least 4–6 hours and simultaneous video recordings of EEG were obtained when required. In patients who required sedation, triclofos (20 mg/kg/dose) was used. The records were saved in compact discs labeled with patient’s identification number. All EEGs were reported by a single, qualified pediatric neurologist, without access to the MRI findings, while blinded to patient identity.
MRI protocol
The standard MRI sequence employed for evaluation included sagittal and axial T1, axial spin-echo proton density and T2, coronal T2, and high-resolution coronal T2 of the mesial temporal lobe structures. Brain MRI scans were routinely prescreened by the attending radiologist and contrast administered when indicated (e.g., mass, inflammation). MRI findings were reported by a single, qualified radiologist, without access to the EEG findings, while blinded to patient identity. All participants were followed up after results of both the investigations were available, which was within 1–2 weeks for all. The final diagnosis was made after review of all the investigations. Families not returning for follow-up within 3 days of their scheduled appointment were contacted telephonically and the follow-up visit was rescheduled. The patients were subsequently followed up every 3 months for any seizure recurrence to ensure compliance to antiepileptic drugs if prescribed and monitor the adverse effects of prescribed antiepileptic drugs. The primary outcome was the proportion of investigations providing clinically relevant information, which alters or influences management. The secondary outcomes were to determine the etiological diagnosis of FAS in the study group, and record adverse events associated with EEG and MRI in children with FAS.
Sample size
Statistical analysis
Demographic and clinical details of all patients were entered in a pre-tested structured proforma. The collected data was entered in MS excel sheet and checked manually for consistency and missing values. The data was statistically analyzed by the statistician using SPSS ver. 21.0 software (IBM SPSS, Inc, Chicago, IL, USA). Chi square/Fisher exact test was used for categorical variables as appropriate. Normally distributed continuous variables were compared by Student t-test and continuous variables with skewed distribution were compared by Wilcoxson rank sum Test. A p-value of less than 0.05 was considered significant.
Results
Discussion
Strengths of the study were, firstly, a thorough follow up of the patients, which was ensured to avoid any bias due to a review of diagnosis after the investigations. Secondly, EEG and MRI brain reporting was done by qualified pediatric neurologists and neuroradiologists, respectively, removing the probability of a false diagnosis. There were a few limitations of this study, the primary one being very few children with an epilepsy syndrome and the other being a delay in getting neuroimaging done for the study participants. A high proportion of children with SSECTL suggests that yield may be different in settings where SSECTL are uncommon.
This study adds to the current knowledge of etiological diagnosis and the yield of diagnostic modalities for the evaluation and treatment of FAS. The results support the precedence of neuroimaging to EEG for evaluation of FAS considering the high incidence of inflammatory granuloma in India, which contrast with the western world guidelines. Additional studies from other centers in India and other developing countries may provide additional information on this topic. The results of our study done in neurologically normal children with FAS showed a high diagnostic yield with an initial MRI. In the light of these results, we recommend that guidelines for evaluation of FAS in children should consider incorporating MRI as the initial investigation, especially in the developing countries.
Conflicts of Interest
Conflict of Interest
The authors declare that they have no conflicts of interest.
Table 1
Baseline patient and disease characteristics of the study population (n=160)
Initial EEG group (n=85) | Initial MRI group (n=75) | p-value | |
---|---|---|---|
Age (years) | 8 (6, 9) | 8 (6,10) | 0.245 |
Weight (kg) | 20 (15.5, 23.5) | 20.0 (17.0, 27.0) | 0.501 |
Height (cm) | 122.0 (112.0, 131.0) | 123.0 (112.0, 133.0) | 0.751 |
Head circumference (cm)* | 46.5 (43.5, 49.0) | 46.5 (44.7, 48.2) | 1.000 |
Male | 46 (54.1) | 42 (56.0) | 0.874 |
Family history of seizure | 13 (15.3) | 7 (9.3) | 0.339 |
Seizure duration, >5 minutes | 71 (83.5) | 58 (77.3) | 0.423 |
Further seizure during hospital stay | 3 (3.5) | 5 (6.7) | 0.476 |
History of NICU admission | 2 (2.3) | 2 (2.6) | 1.000 |
Generalized Seizure | 48 (56.5) | 48 (64.0) | 0.623 |
Focal seizure | 37 (43.5) | 27 (36.0) | 0.332 |
Table 2
Results of investigations and etiological diagnosis in children with first seizure (n=160)
Initial EEG group (n=85) | Initial MRI group (n=75) | p-value | |
---|---|---|---|
Abnormal test result on first investigation | 52 (61.2) | 53 (70.6) | 0.244 |
Etiological diagnosis with initial investigation | 0 (0.0) | 53 (70.6) | 0.000 |
Time taken for investigation (days) | 3 (2, 5) | 10 (4, 22) | <0.001 |
Hospital visits* | 3 (1, 3) | 3 (2, 3) | 0.001 |
Table 3
Distribution of etiologic diagnosis across the study groups (n=160)
Table 4
Distribution of etiologic diagnosis in the combined study
Total (n=160) | Generalized seizure (n=96; 60%) | Focal seizure (n=64; 40%) | p-value | |
---|---|---|---|---|
Inflammatory granuloma | 94 (58.75) | 49 (51.04) | 45 (70.31) | 0.015 |
Remote symptomatic | 14 (8.75) | 9 | 5 | 0.731 |
Structural malformation* | 3 (1.9) | 2 | 1 | 0.811 |
Idiopathic | 24 (15.0) | 16 | 8 | 0.469 |
Epilepsy syndrome, temporal lobe epilepsy | 1 (0.6) | 0 | 1 | |
FUS | 24 (15.0) | 20 (28.98) | 4 (6.25) | 0.011 |
References



















Comments are closed.